Cleared Traditional

K223745 - Novae Dual Mobility System

K223745 is an FDA 510(k) clearance for Novae Dual Mobility System, manufactured by Serf. The device is a Class 2 Orthopedic device with product code LZO cleared through the Traditional 510(k) pathway after a 373-day FDA review.

K223745 · Serf · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2023
Decision
373d
Days
Class 2
Risk

K223745 is an FDA 510(k) clearance for the Novae® Dual Mobility System, Hype® Hip System. Classified as Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented (product code LZO), Class II - Special Controls.

Submitted by Serf (Decines Charpieu, FR). The FDA issued a Cleared decision on December 22, 2023 after a review of 373 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3353 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Serf devices

FDA 510(k) Submission Details - K223745

510(k) Number K223745 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 14, 2022
Decision Date December 22, 2023
Days to Decision 373 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
251d slower than avg
Panel avg: 122d · This submission: 373d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LZO Device Classification - Class 2, Special Controls

Product Code LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3353
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

BioVera, Inc.
Robert A Poggie

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented

All 454
Devices cleared under the same product code (LZO) and FDA review panel - the closest regulatory comparables to K223745.
Ceramic Femoral Head
K240452 · Microport Orthopedics, Inc. · Apr 2024
28mm/38D MDM X3 Insert for MDM Liner
K233724 · Howmedica Osteonics Corp., Dba Stryker Orthopaedics · Mar 2024
Z1 Hip System
K233476 · Orchard Medical Development · Feb 2024
Actinia® hip stems
K232371 · Implantcast GmbH · Oct 2023
EMPHASYS Femoral Stems
K233233 · Depuy Ireland UC · Oct 2023
MINIMA S System
K231925 · Lima Corporate S.P.A. · Jul 2023